Limited evidence and a significant time burden stand in the way of hyperbaric oxygen therapy becoming a more routine treatment for chronic radiation side effects in breast cancer.
The nonspecific symptoms of lichen sclerosus often lead to a missed or delayed diagnosis, exacerbating the challenges that patients with the condition face.
Gilead Sciences said on Thursday enrollments to test its cancer drug, magrolimab, on solid tumors had been paused globally, a week after the U.S. regulator put some studies.
A research team of Canadian and French scientists, led by INRS professor Maya Saleh, has been investigating immunotherapy resistance in certain patients with hepatocellular carcinoma (HCC) associated with steatotic liver disease.